APA (7th ed.) Citation

J, M., Y, C., Q, Z., C, L., J, X., Y, W., . . . Y, D. (2024). Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo. Frontiers in immunology, 15, 1364161. https://doi.org/10.3389/fimmu.2024.1364161

Chicago Style (17th ed.) Citation

J, Mao, et al. "Corilagin Alleviates Atherosclerosis by Inhibiting NLRP3 Inflammasome Activation via the Olfr2 Signaling Pathway in Vitro and in Vivo." Frontiers in Immunology 15 (2024): 1364161. https://doi.org/10.3389/fimmu.2024.1364161.

MLA (9th ed.) Citation

J, Mao, et al. "Corilagin Alleviates Atherosclerosis by Inhibiting NLRP3 Inflammasome Activation via the Olfr2 Signaling Pathway in Vitro and in Vivo." Frontiers in Immunology, vol. 15, 2024, p. 1364161, https://doi.org/10.3389/fimmu.2024.1364161.